Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Okin

Showing results (71-80 of 171) with videos related to

Pageof 18
Sort By:
Hypertension (Dallas, Tex. : 1979)|March 24, 2004
QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention for Endpoint Reduction in Hypertension StudyLasse Oikarinen, Markku S Nieminen, Matti Viitasalo, et al.
Circulation. Arrhythmia and Electrophysiology|February 14, 2013
Relationship of sudden cardiac death to new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophyPeter M Okin, Casper N Bang, Kristian Wachtell, et al.
Hypertension (Dallas, Tex. : 1979)|October 14, 2015
Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure TrialElsayed Z Soliman, Robert P Byington, J Thomas Bigger, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|November 1, 2019
Association Between Troponin Levels and Visceral Infarction in Patients with Acute Ischemic StrokeShobana Ramasamy, Praneil Patel, Ajay Gupta, et al.
Annals of Epidemiology|December 20, 2014
Atrial fibrillation incidence and risk factors in relation to race-ethnicity and the population attributable fraction of atrial fibrillation risk factors: the Multi-Ethnic Study of AtherosclerosisCarlos J Rodriguez, Elsayed Z Soliman, Alvaro Alonso, et al.
Hypertension (Dallas, Tex. : 1979)|September 26, 2007
In-treatment resolution or absence of electrocardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) StudyPeter M Okin, Richard B Devereux, Katherine E Harris, et al.
Journal of the American Heart Association|April 16, 2025
Independent and Incremental Value of ECG Markers for Prediction of Cancer Therapy-Related Cardiac DysfunctionIshmam Ibtida, Xiaoyue Ma, Mohammed Al-Sadawi, et al.
Hypertension (Dallas, Tex. : 1979)|June 10, 2015
Effect of lower on-treatment systolic blood pressure on the risk of atrial fibrillation in hypertensive patientsPeter M Okin, Darcy A Hille, Anne Cecilie K Larstorp, et al.
American Journal of Hypertension|April 17, 2010
Greater regression of electrocardiographic left ventricular hypertrophy during hydrochlorothiazide therapy in hypertensive patientsPeter M Okin, Darcy A Hille, Sverre E Kjeldsen, et al.
The American Journal of Cardiology|April 19, 2017
Comparison of QRS Duration and Associated Cardiovascular Events in American Indian Men Versus Women (The Strong Heart Study)Jason F Deen, Dorothy A Rhoades, Carolyn Noonan, et al.
Pageof 18

Showing results (71-80 of 171) with videos related to

Sort By:
Pageof 18
Hypertension (Dallas, Tex. : 1979)|March 24, 2004
QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention for Endpoint Reduction in Hypertension StudyLasse Oikarinen, Markku S Nieminen, Matti Viitasalo, et al.
Circulation. Arrhythmia and Electrophysiology|February 14, 2013
Relationship of sudden cardiac death to new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophyPeter M Okin, Casper N Bang, Kristian Wachtell, et al.
Hypertension (Dallas, Tex. : 1979)|October 14, 2015
Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure TrialElsayed Z Soliman, Robert P Byington, J Thomas Bigger, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|November 1, 2019
Association Between Troponin Levels and Visceral Infarction in Patients with Acute Ischemic StrokeShobana Ramasamy, Praneil Patel, Ajay Gupta, et al.
Annals of Epidemiology|December 20, 2014
Atrial fibrillation incidence and risk factors in relation to race-ethnicity and the population attributable fraction of atrial fibrillation risk factors: the Multi-Ethnic Study of AtherosclerosisCarlos J Rodriguez, Elsayed Z Soliman, Alvaro Alonso, et al.
Hypertension (Dallas, Tex. : 1979)|September 26, 2007
In-treatment resolution or absence of electrocardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) StudyPeter M Okin, Richard B Devereux, Katherine E Harris, et al.
Journal of the American Heart Association|April 16, 2025
Independent and Incremental Value of ECG Markers for Prediction of Cancer Therapy-Related Cardiac DysfunctionIshmam Ibtida, Xiaoyue Ma, Mohammed Al-Sadawi, et al.
Hypertension (Dallas, Tex. : 1979)|June 10, 2015
Effect of lower on-treatment systolic blood pressure on the risk of atrial fibrillation in hypertensive patientsPeter M Okin, Darcy A Hille, Anne Cecilie K Larstorp, et al.
American Journal of Hypertension|April 17, 2010
Greater regression of electrocardiographic left ventricular hypertrophy during hydrochlorothiazide therapy in hypertensive patientsPeter M Okin, Darcy A Hille, Sverre E Kjeldsen, et al.
The American Journal of Cardiology|April 19, 2017
Comparison of QRS Duration and Associated Cardiovascular Events in American Indian Men Versus Women (The Strong Heart Study)Jason F Deen, Dorothy A Rhoades, Carolyn Noonan, et al.
Pageof 18